TB-500

⏱ Half-Life

Moderate duration profile

TB-500 demonstrates a moderate half-life characteristic in research literature, shaping how observation windows and study timelines are typically structured.

⚡ Onset Characteristics

Moderate measurable response

Onset is observed as moderate — a property that influences how researchers structure comparative studies versus other compounds in the recovery research category.

🧠 Key Notes

What makes it distinct

• 01Studied alongside BPC-157 in recovery research models
• 02Active fragment of Thymosin Beta-4
• 03Investigated for systemic vs localised distribution

🧬 Mechanism of Action

How it works

TB-500 is the synthetic active region of Thymosin Beta-4, a naturally occurring 43-amino-acid peptide. Its primary biological action is binding G-actin and regulating actin polymerisation — the cytoskeletal process that drives cell migration. By upregulating actin expression and mobilising progenitor cells to sites of injury, TB-500 promotes coordinated repair across multiple tissue types. It also supports new blood-vessel formation (angiogenesis through VEGF signalling), reduces inflammation, and demonstrates systemic distribution after subcutaneous administration — making it a whole-body repair signal rather than a localised one.

✨ Documented Benefits

What the research shows it supports

🔍 Research Insights

What the literature shows

🧪 Typical Research Use Cases

Where it appears in study design

📚 References

Peer-reviewed literature

Primary research sources cited on this profile. All links resolve to PubMed or the publishing journal.

1. [01]

   Goldstein, A. L., Hannappel, E., Sosne, G., & Kleinman, H. K. (2012). Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opinion on Biological Therapy, 12(1), 37–51.

   Expert Opinion on Biological Therapy ↗
2. [02]

   Crockford, D., Turjman, N., Allan, C., & Angel, J. (2010). Thymosin β4: structure, function, and biological properties supporting current and future clinical applications. Annals of the New York Academy of Sciences, 1194, 179–189.

   Annals of the NY Academy of Sciences ↗
3. [03]

   Bock-Marquette, I. et al. (2004). Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature, 432(7016), 466–472.

   Nature ↗
4. [04]

   Philp, D. & Kleinman, H. K. (2010). Animal studies with thymosin β4, a multifunctional tissue repair and regeneration peptide. Annals of the New York Academy of Sciences, 1194, 81–86.

   Annals of the NY Academy of Sciences ↗